CYTH - Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport | Benzinga
Applied Molecular Transport Inc (NASDAQ: AMTI) has agreed to merge with Cyclo Therapeutics Inc (NASDAQ: CYTH) in an all-stock transaction.
Following the merger's closing, the combined company will operate under Cyclo Therapeutics and continue trading on The Nasdaq Capital Market under the CYTH ticker.
The combined company will focus on advancing Cyclo Therapeutics' pivotal Phase 3 global ...